top of page

Market Surveillance and Control: Medical Device Regulation Articles 90-97, Recall, Withdrawal from the Market and ÜTS Withdrawal Notification

12 hours ago
9 min read
Tıbbi cihaz piyasa gözetimi ve denetimi geri çağırma

SUMMARY

Market surveillance and control means the activities carried out and measures taken by the Agency, under the Tıbbi Cihaz Yönetmeliği (Medical Device Regulation), to check that devices meet the requirements and do not endanger health, safety or the public interest. The Regulation governs this process in Part Seven, Chapter Three, Articles 90 to 97.

This article gives, as direct quotations from the Regulation and the guideline, the definitions, the Agency’s inspection powers, the risk and non-compliance procedures, the recall and withdrawal measures, and withdrawal notifications in ÜTS.

For your ÜTS records and individual notifications: Medical Device ÜTS Registration Consultancy

Contents

1. Definitions: Market Surveillance, Recall, Withdrawal from the Market

Tıbbi Cihaz Yönetmeliği, Art. 3, paragraph 1:

“rr) Market surveillance and control: The activities carried out and measures taken by the Agency to check and ensure that devices meet the requirements set out in the relevant European Union harmonization legislation and do not endanger health, safety or other aspects of the protection of the public interest,”

“ö) Recall: Any measure aimed at achieving the return of a device that has already been made available to the end user to the economic operator,”

“şş) Withdrawal from the market: Any measure aimed at preventing a device in the supply chain from being made available on the market,”

“l) Corrective action: The action carried out to eliminate the cause of a potential or existing non-conformity or other undesirable situation,”

A recall concerns a device that has reached the end user; a withdrawal from the market concerns a device in the supply chain. The difference between the two concepts is explained in our article on the difference between recall and withdrawal from the market.

2. The Agency’s Controls and Inspections: Art. 90

“(1) Where appropriate, the Agency carries out appropriate checks on the conformity of the characteristics and performance of devices, including a documentation review and physical or laboratory tests based on adequate samples. In particular, the Agency takes into account accepted principles regarding risk assessment and risk management, vigilance data and complaints.”

Third paragraph:

“(3) In carrying out the activities referred to in the first paragraph, the Agency;”

  • “a) may require economic operators to make available the necessary documentation and information and, where justified, to provide the necessary device samples free of charge or to give access to the devices.”

  • “b) carries out announced and, where necessary, unannounced inspections at the premises of economic operators, together with suppliers and/or contractors, and where necessary at the premises of professional users.”

“(5) Where necessary to protect public health, the Agency may take the necessary measures to seize devices that are counterfeit or present an unacceptable risk, may destroy them or otherwise render them inoperable.”

Under the second paragraph, the Agency prepares annual surveillance and inspection activity plans.

3. Inspection Report and Submitting Comments

“(6) Following each inspection carried out for the purposes referred to in the first paragraph, the Agency prepares a report on the inspection findings concerning compliance with the legal and technical requirements applicable under this Regulation. The report specifies the necessary corrective actions.”

“(7) The Agency communicates the content of the report referred to in the sixth paragraph to the economic operator subject to the inspection. Before adopting the final report, the Agency gives the economic operator concerned the opportunity to submit comments. This final inspection report is entered into the electronic system referred to in Article 97.”

4. Assessment of a Suspected Device: Art. 91

“(1) Where, on the basis of data obtained from vigilance or market surveillance and control activities or other information, the Agency has reason to believe that a device;”

  • “a) may present an unacceptable risk to the health or safety of patients, users or other persons, or to other aspects of the protection of public health, or”

  • “b) does not comply with the requirements set out in this Regulation,”

“it carries out an assessment of the device concerned covering all the requirements set out in this Regulation relating to the risk presented by the device or its other non-compliances. The economic operators concerned cooperate with the Agency and other competent authorities.”

If an unacceptable risk is identified at the end of the assessment, Article 92 applies; if a non-compliance without risk is identified, Article 94 applies. For vigilance data, see our article on vigilance and serious adverse event reporting.

5. Devices Presenting an Unacceptable Risk: Art. 92

When the Agency identifies an unacceptable risk, it requires the manufacturer, the authorized representative and all other economic operators concerned, within a reasonable period that is clearly defined and communicated:

  • “a) bringing the device into compliance with the requirements of this Regulation relating to the risk it presents,”

  • “b) restricting the making available of the device on the market, subjecting its making available to specific requirements, withdrawing the device from the market or recalling it, proportionately to the nature of the risk,”

“to take, without delay, all appropriate and duly justified corrective actions aimed at the above.”

“(3) Economic operators referred to in the first paragraph ensure that all appropriate corrective actions are taken without delay in respect of all the relevant devices they have made available on the market, throughout Türkiye and the EU.”

“(4) Where an economic operator referred to in the first paragraph does not take adequate corrective action within the period referred to in the same paragraph, the Agency takes all appropriate measures to prohibit or restrict the making available of the device on the market, to withdraw it from the market or to recall it.”

“(5) The notification referred to in the fourth paragraph includes in particular all available details, namely the data necessary for the identification and traceability of the non-compliant device, the origin of the device, the nature and the reasons of the alleged non-compliance and the related risk, the nature and duration of the measures taken and the arguments put forward by the economic operator concerned.”

Under the second paragraph, if a certificate has been issued for the device under Article 56, the Agency also notifies the results to the notified body that issued the certificate. Under the seventh paragraph, if there is no objection within 2 months of notification to a measure taken by a competent authority, the measure becomes valid; in case of objection, the Commission’s assessment under Article 93 is awaited.

6. Other Non-Compliances: Art. 94

“(1) Where, following an assessment under Article 91, the Agency finds that a device does not comply with the requirements set out in this Regulation but does not present an unacceptable risk to the health or safety of patients, users or other persons or to other aspects of the protection of public health, it requires the economic operator concerned to put an end to the non-compliance within a reasonable period that is clearly defined, communicated to that economic operator and proportionate to the non-compliance.”

“(2) Where the economic operator does not put an end to the non-compliance within the period referred to in the first paragraph, the Agency, without delay, takes all appropriate measures to restrict or prohibit the making available of the product on the market, or to ensure its recall or withdrawal from the market.”

7. Preventive Health Protection Measures: Art. 95

“(1) After carrying out an assessment indicating a potential risk related to a device or a specific category or group of devices, where the Agency considers that, in order to protect the health and safety of patients, users or other persons or other aspects of public health, the making available on the market or putting into service of a device or a specific category or group of devices should be prohibited, restricted or made subject to specific requirements, or that such a device or category or group of devices should be withdrawn from the market or recalled, it may take any necessary and justified measures.”

The measure can be taken for a single device as well as for a specific category or group of devices. Under the third paragraph, if the Commission has no decision on the grounds within 6 months of notification, the measures are considered justified.

8. Good Administrative Practice and the Electronic System: Art. 96 and 97

“(1) Each measure taken by the Agency under Articles 92 to 95 states all the grounds on which it is based. If the measure is directed at a specific economic operator, the Agency informs the economic operator concerned of the measure taken without delay, and at the same time informs it of the legal remedies available and the statutory time limits for appeals.”

“(2) Except in cases requiring urgent action due to an unacceptable risk to human health or safety, the economic operator concerned is given the opportunity to submit its views to the Agency within an appropriate, clearly defined period before any measure is taken.”

“(3) Where the economic operator demonstrates that it has taken effective corrective action and that the device complies with the requirements of this Regulation, any measure taken is withdrawn or amended promptly.”

Under Article 97, the Commission’s electronic system contains summaries of the results of inspections, final inspection reports, and information on devices presenting an unacceptable risk, non-compliance of products and preventive measures.

9. Withdrawal Notifications in ÜTS

TİTCK ÜTS Individual Movement Notifications Guideline (Tekil Hareket Bildirimleri Kılavuzu), Part Five “Ürün Geri Çekme İşlemleri” (Product Withdrawal Procedures), Art. 18:

“Article 18- (1) A withdrawal decision is issued for a product that TİTCK or the manufacturer/importer placing the product on the market finds unsuitable for use. The movement of individual products for which a withdrawal decision has been issued to the relevant institutions, to be subjected to corrective action or not to be placed on the market again, is made only with the ‘Geri Çekme Verme Bildirimi’ (Withdrawal Giving Notification).”

“(2) A giving notification cannot be used for individual products subject to a withdrawal decision.”

Art. 19:

“Article 19- (1) To accept individual products given with a withdrawal giving notification, a ‘Geri Çekme Alma Bildirimi’ (Withdrawal Receiving Notification) is made by the institution/company.”

“(3) No new production/import notification can be made for a lot number for which a withdrawal decision has been issued.”

Art. 23, rectification/corrective action notification:

“(3) Products subject to a withdrawal decision are not allowed to be placed on the market again without a rectification/corrective action notification.”

Under Art. 21, the reasons that can be selected in a destruction/disposal notification include ‘Kurum kararı’ (Agency decision) and ‘Gönüllü geri çekme’ (Voluntary withdrawal). The operations that can be performed under Art. 26 for devices subject to a withdrawal decision:

  • “Geri Çekme Verme ve İptali” (Withdrawal Giving and Cancellation),

  • “Geri Çekme Alma” (Withdrawal Receiving),

  • “Islah / Düzeltici Faaliyet ve İptali” (Rectification / Corrective Action and Cancellation),

  • “İmha / Bertaraf ve İptali” (Destruction / Disposal and Cancellation),

  • “Hastanın Vücudundan Çıkarma ve İptali” (Removal from the Patient’s Body and Cancellation),

  • “Tüketiciden İade Alma ve İptali” (Return from Consumer and Cancellation),

  • “Kullanımdan Alma ve İptali” (Taking out of Use and Cancellation)

For the general operation of individual notifications, see our article on ÜTS individual movement notifications, and for the scope of our service, see our page on ÜTS individual notification services. For the manufacturer’s own surveillance obligations, see our article on post-market surveillance and PSUR.

10. Frequently Asked Questions

Can TİTCK carry out an unannounced inspection?

Yes. Under Article 90, paragraph 3, subparagraph (b), the Agency carries out announced and, where necessary, unannounced inspections at the premises of economic operators and, where necessary, professional users.

Can comments be submitted on the inspection report?

Under Article 90, paragraph 7, the Agency gives the economic operator subject to the inspection the opportunity to submit comments before adopting the final report.

Can a device be withdrawn from the market even if there is no risk?

Under Article 94, the Agency first notifies that the non-compliance must be ended within a reasonable period. If it is not ended within the period, it takes measures to restrict or prohibit making available on the market, or to recall or withdraw the device.

What is the difference between recall and withdrawal from the market?

Under Article 3, a recall is a measure aimed at returning a device made available to the end user to the economic operator; a withdrawal from the market is a measure aimed at preventing a device in the supply chain from being made available on the market.

How is a product subject to a withdrawal decision moved in ÜTS?

Under Art. 18 of the Individual Movement Notifications Guideline, only with a “Geri Çekme Verme Bildirimi” (Withdrawal Giving Notification); under Art. 19 the other party makes a “Geri Çekme Alma Bildirimi” (Withdrawal Receiving Notification). A giving notification cannot be used for these products.

For your ÜTS records and individual notifications: Medical Device ÜTS Registration Consultancy

Sources

 
 

Medical Device ÜTS Registration Consultancy

Request an ÜTS registration consultancy quote

Ehlibeyt Mahallesi, Tekstilciler Caddesi No: 35/7 06520 Çankaya / Ankara - TÜRKİYE

Cevizli Mahallesi, Zuhal Caddesi Ritim İstanbul B Blok, No:44 Maltepe / İstanbul - TÜRKİYE

info@medexmedikal.com
+90 505 580 4622
+90 312 389 1354

ÜTS Guides · Legislation Calendar · Glossary · ÜTS Guide Index · Frequently Asked Questions

Services: ÜTS Consultancy · Who Carries Out the ÜTS Registration? · ÜTS Document Registration Consultancy · ÜTS Product Registration Consultancy · Importer ÜTS Registration Consultancy · Sales Centre Authorisation Certificate · EUDAMED Registration Consultancy · MDR/IVDR Declaration of Conformity · Technical File Preliminary Review · Label and Instructions for Use Check · PRRC Service · PMS and PSUR · Clinical Evaluation · EMDN and GMDN Code Determination · Certificate of Free Sale · EUDAMED XML Generator · ÜTS Registration Training · Correction of a Rejected ÜTS Application

KVKK and Privacy Policy | Cookie Policy | Accessibility Statement

© 2026 Medex Kurumsal Danışmanlık Ltd. Şti.

bottom of page
WhatsApp Hemen Ara